This trial is active, not recruiting.

Condition undernutrition
Treatment no intervention
Sponsor University Hospital, Geneva
Start date September 1998
End date May 2016
Trial size 4152 participants
Trial identifier NCT02463565, Quality control programme


Food provision and consumption were assessed for all hospitalized patients over a 24h-period survey. This study is a part of a control quality programme and is performed every 4 years since 1999.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective cross-sectional
no intervention

Primary Outcomes

Hospital food provided, consumed and wasted measured in energy (kcal) and gram of proteins
time frame: 24 hours

Secondary Outcomes

Percentage of underfed patients
time frame: 24 hours
Hospital meal quality assessed by questionnaire
time frame: 24 hours
Presence of healthcare-associated infections
time frame: 24 hours

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - All hospitalized patients Exclusion Criteria: - Exclusive enteral or parenteral nutrition - Patients who do not receive three meals

Additional Information

Official title Assessment of Food Intake in Hospitalized Patients: A Prospective Hospital Survey
Description During one day, a team of dieticians assessed food provided, consumed and reasons for non-consumption in all hospitalized patients receiving 3 meals/day. Oral nutritional supplements, supplemental enteral and parenteral nutrition were taken into account. Nutritional needs were calculated according to the ESPEN recommendations. Amount of energy and proteins provided and consumed were calculated using the nutrient analysis software Winrest (FSI, Noisy-le-grand, France). In 2012, the presence of healthcare-associated infections was recorded during this study.
Trial information was received from ClinicalTrials.gov and was last updated in January 2017.
Information provided to ClinicalTrials.gov by University Hospital, Geneva.